GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Blackrock Health Sciences Trust (NYSE:BME) » Definitions » Future 3-5Y EPS without NRI Growth Rate

BME (Blackrock Health Sciences Trust) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Dec. 14, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Blackrock Health Sciences Trust Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate

For the Asset Management subindustry, Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate falls into.


Blackrock Health Sciences Trust  (NYSE:BME) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Blackrock Health Sciences Trust Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Blackrock Health Sciences Trust's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Blackrock Health Sciences Trust Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Blackrock Health Sciences Trust (NYSE:BME) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BHK ETJ WIW LDP BGY HFRO IFN PFN PRIF EMD BLK BX OSTO:INVE A TSX:BN KKR APO BK AMP XSWX:PGHN LSE:III
Traded in Other Exchanges
N/A
Address
100 Bellevue Parkway, Wilmington, DE, USA, 19809
Website
https://www.blackrock.com
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
Executives
Arthur Philip Steinmetz director 50 HUDSON YARDS, NEW YORK NY 10001
Aaron David Wasserman officer: Chief Compliance Officer 50 HUDSON YARDS, NEW YORK NY 10001
Lorenzo Flores director 2100 LOGIC DRIVE, SAN JOSE CA 95124
James Phillip Holloman director P.O. BOX 625737, 6800 CINTAS BOULEVARD, CINCINNATI OH 45262
Stayce D. Harris director 1999 S. BASCOM AVE., SUITE 700, CAMPBELL CA 95008
Trent Walker officer: Chief Financial Officer C/O PIMCO, 650 NEWPORT CENTER DRIVE, NEWPORT BEACH CA 92660
Xiang Liu other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Jeffrey Gene Lee other: Portfolio Manager 55 EAST 52ND STREET, NEW YORK NY 10055
Kyle Mcclements other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Christopher Accettella other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
H Erin Xie other: Portfolio Manager 100 BELLEVUE PARKWAY, WILMINGTON DE 19809
Cynthia Egan director 7117 BELLONA AVENUE, BALTIMORE MD 21212
Robert W Fairbairn director 55 EAST 52ND STREET, NEW YORK NY 10055
Catherine A. Lynch director 55 EAST 52ND STREET, NEW YORK NY 10055
Jonathan Diorio officer: Vice President 55 EAST 52ND STREET, NEW YORK NY 10055